Drug application
PREDNISOLONE SODIUM PHOSPHATE (PREDNISOLONE SODIUM PHOSPHATE)
Drugs@FDA ANDA 202179 · RISING
Key facts
| Drug name | PREDNISOLONE SODIUM PHOSPHATE |
|---|---|
| Active ingredients | PREDNISOLONE SODIUM PHOSPHATE |
| Application type | ANDA |
| Application number | 202179 |
| Company | RISING |
| Dosage forms | TABLET, ORALLY DISINTEGRATING, ORAL |
| Strength | EQ 10MG BASE |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission class | Not Applicable |
| Latest submission status date | Apr 10, 2013 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.